Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 863

Document Document Title
JP3789951B2
PURPOSE: To obtain a new compound capable of producing hydantocidin in high yield without forming stereoisomers. CONSTITUTION: This sugar derivative is a compound of formula I [R1 and R2 each is H or together form a (substituted) alkylid...  
JP2006514071A
The invention relates to novel pharmaceutically acceptable salts of anticonvulsant derivatives, processes for preparation of and pharmaceutical compositions containing said salts, useful in the treatment of epilepsy.  
JP2006508949A
The present invention is directed to a continuous process for the preparation of fructopyranose sulfamate derivatives of the general formula (I)  
JP2006052182A
To provide a method for producing a fluorinated purine nucleoside derivative, by which the 3-position (preferably the α-position) is economically and efficiently fluorinated and which is suitable for industrial production.This method fo...  
JP2006502103A
The invention relates to a novel palatinose condensation product which is obtained by condensing the disaccharide palatinose in a molten mass of palatinose, water and an organic acid.  
JP3725233B2
To obtain a trehalose derivative excellent in surface-active ability and safety to skin and useful as a surfactant, etc., capable of using for cosmetics, medicines, foods, etc., by reacting trehalose with an acetal compound in the presen...  
JP2005536493A
The present invention relates to the production method of the アルキルアミノグルコサミニドホス compound which contains like various new intermediate fields and Takumi Nakama, and a disaccharide compound. Glycosyl halide i...  
JP2005289964A
To provide an efficient production method of a 2-deoxy-L-ribose compound and its protection compound.This production method comprises reacting an aldehyde compound represented by formula (1) (wherein R1 and R2 are each independently or i...  
JP3706875B2
To provide tea leaves with reduced caffeine content, capable of being taken by a large amount for a long time as an antiallergic beverage or food. A method for producing tea leaves is provided by immersing any of raw leaves of "Benifuuki...  
JP2005530808A
This invention relates to a new pharmaceutically useful compound which is a stoichiometrically 1:1 adduct of tramadol hydrochloride and topiramate, to the manufacture and use thereof.  
JP2005526813A
Are a compound of formula (I), and n is 0 or 1, and here; R6 and R7, Are hydrogen, or become together, form carbonyl oxygen, and; R1, Hydrogen; *N (Z) Y and *C (Z) When it is chosen from the group which consists of Y and R1 is *N (Z) Y h...  
JP2005526852A
The present invention is directed to novel compounds of the formula (I) wherein X, R1, R2, R3, R4, R5 and R6 are as described in the specification, processes for the preparation of and pharmaceutical compositions comprising said derivati...  
JP3662954B2
PURPOSE: To obtain the subject compound, useful for a raw material, etc., for liquid crystals, medicines, agrochemicals, etc., by optically resolving a recemic 1-benzyloxy-6,6,6-trifluoro-4-hexyn-3-ol, then carrying out the reduction of ...  
JPWO2003072587A1
本出願には、システイン若しくは/およびシ ステイニルグリシンまたはシスチンと還元糖 とを水性溶媒中に加熱下に保持することを特 徴とする不揮発性チアゾリジン化合物の...  
JP2005514352A
The present invention is directed to a method for treating autoimmune diseases comprising administering a therapeutically effective amount of a compound of the following formula (I) wherein X, R1, R2, R3, R4, R5 and R6 are as herein defi...  
JP2005509615A
A compound of the formula : wherein R 1 is -H, -SPh, -Ph, -allyl or -benzyl; R 2 is -H, -Et, -allyl, -Me or -benzyl; R 3 is -H, -Et, -Me, -allyl or -benzyl; and R 4 and R 5 are both -OH or R 4 and R 5 together form a ring and are -OCH(Ph...  
JP3621097B2
The present invention relates to a method of preparing BCH-189 and various analogues of BCH-189 from inexpensive precursors with the option of introducing functionality as needed. This synthetic route allows the stereoselective preparati...  
JP2005503358A
The present invention includes compounds and compositions of beta-halonucleosides, as well as methods to treat HIV, HBV or abnormal cellular proliferation comprising administering said compounds or compositions.  
JP2004537533A
The present invention relates to the method for the protection of an optic nerve cell using the optic nerve cytoprotective agent and this スルファ mate derivative which are characterized by containing the スルファ mate derivative...  
JP3602050B2
A composition comprises 12,13-(Pyranosyl)-indolo(2,3-a)pyrrolo(3,4-c)carbazole and 12,13-(pyranosyl)-furo(3,4-c)indolo(2,3-a)carbazole derivatives (I), or their isomers, salts with acids or bases, are new A composition comprises 12,13-(P...  
JP2004262911A
To provide a method for producing effectively an optically active α-aminoketone.A method for producing an optically active α-aminoketone shown by general formula (2) comprises allowing a new chiral alkoxide originating from glucose, wh...  
JPWO2002096921A1
本発明はアポトーシスを誘導する新規なグル コース誘導体およびその医薬としての使用に 関する。本発明のグルコース誘導体は、次一 般式(I)[式中、X、Y、Zは同一ま...  
JP2004526984A
A chemically amplified photoresist composition comprising, (a) a compound which cures upon the action of an acid or a compound whose solubility is increased upon the action of an acid; and (b) as photosensitive acid donor, at least one c...  
JP2004222682A
To provide tea leaves with reduced caffeine content, capable of being taken by a large amount for a long time as an antiallergic beverage or food.A method for producing tea leaves is provided by immersing any of raw leaves of "Benifuuki"...  
JP2004523478A
The present invention relates to novel N12, N13-bridged sugar derivatives of indolylopyrrolocarbazoles and pharmaceutical formulations thereof which exhibit topoisomerase-I activity and are useful in inhibiting the proliferation of tumor...  
JP2004182664A
To provide a method for efficiently and safely carrying out fluorination of saccharide in high selectivity.The specific part of saccharide can selectively and simply be fluorinated without having influence on the protective groups by rea...  
JP2004518803A
Avilamycin derivatives, gene technology biosynthesis processes for their production, medications containing these compounds, as well as the use of these compounds for the production of a active agent against infectious diseases, as well ...  
JP2004175792A
To provide a method for simply producing a 2,2'-anhydro-1-(β-D-arabinofuranosyl)uracil compound at a low cost.This method for producing the 2,2'-anhydro-1-(β-D-arabinofuranosyl)uracil compound comprises heating a 3',5'-O-sulfinylxylour...  
JP2004517932A
The present invention provides stable compounds prepared from boronic acid and lyophilized compounds thereof of formula (1) in which Z 1 and Z 2 are moieties derived from sugar. The invention also provides methods for preparing such comp...  
JP2004517931A
The present invention provides stable compounds prepared from boronic acid and lyophilized compounds thereof of formula (1) in which Z 1 and Z 2 are moieties derived from sugar. The invention also provides methods for preparing such comp...  
JP2004123605A
To provide a method for highly selectively, efficiently and safely advancing the fluorination reaction of a desired substrate.This fluorination method comprises reacting a specific fluorine compound such as N, N-diethyl-α, α-difluoro-(...  
JP2004510700A
Anticonvulsant derivatives useful for preventing the development of Type II diabetes mellitus and Syndrome X are disclosed.  
JP3516959B2
Methods and compositions are provided which increase the cellular uptake of bioactive materials by covalently bonding such compounds to carbohydrate moieties through chemical linkers using other than glycosidic bonds. Numerous carbohydra...  
JP2004505004A
Anticonvulsant derivatives useful in lowering blood pressure in overweight individuals.  
JP2003530300A
Anticonvulsant derivatives useful in maintaining weight loss.  
JP2003527324A
(57) -- summary type (I) -- the heterocyclic aromatic amide (HAA) according to 化 1 this specification defines X*X, M, Z, and A among a formula]. The present invention includes the water ghost, the salt, and the complex of that again. T...  
JP2003212892A
To provide a lactosamine derivative also useful as an intermediate for synthesis of various kinds of oligosaccharides, and to provide a method for efficiently producing the lactosamine derivative.This new lactosamine derivative is repres...  
JP3430318B2
PURPOSE: To provide halistatin 1 which is useful as a material for anticancer drugs. CONSTITUTION: Halistatin 1 is shown by the formula. This compound is obtained from the sponge Phkellia-carteri gathered in the west Indian Ocean by extr...  
JP3430317B2
PURPOSE: To provide halistatin 2 which exerts, as an anti-tumor agent, a particularly excellent activity against leukemia, small cell carcinoma of lung, large bowel cancer, CNS cancer and melanoma. CONSTITUTION: The halistatin 2 is shown...  
JP2003176250A
To provide a method of synthesizing phosphine oxide being a synthon for ring A used for preparing 19-nor-vitamin D compound and provide a new synthetic intermediate that is formed on the way of the synthetic route.In this new synthetic p...  
JP3411280B2
A method for vacuum distillation includes separation of a liquid product delivered to a reservoir under vacuum into a vapour-gaseous phase and at least one liquid fraction, withdrawal of the vapour-gaseous phase from the reservoir using ...  
JP3403218B2
PURPOSE: To provide a new compound useful as an antiliphemic and for treating liver disorders with cholestasis with no side-effects, which has activity to decrease the cholesterol level in the serum and has high affinity for transport sy...  
JP2003055394A
To provide a synthetic compound which is useful for obtaining an oligo saccharide specifically bound to a target nucleic acid in the specific sequence of a gene, and to enable the enhancement in the effect of an anti-gene method. This di...  
JP2003505465A
Anticonvulsant compounds of the general formula I:where X, R1, R2, R3, R4, R5, and R6 are as herein defined; are useful in treating acute ischemia-induced neurodegeneration, such as occurs during and after stroke, head trauma, spinal inj...  
JP2003502325A
The invention relates to a method for the enantiomer separation of cis-8-benzyl-7,9-dioxo-2,8-diazabicy-clo[4.3.0]nonane (also described below as cis-6-benzyl-5,7-dioxooctahydropyrrolo[3,4-b]pyridine or dioxopyrrolopiperidine). The inven...  
JP2003012683A
To provide a simple method for the production of a sugar oxazoline derivative.The sugar oxazoline derivative expressed by general formula (2) (R1 is H or (CH2)n-CH3 ((n) is 0-5); R2, R3, R4, R5 and R6 are each independently H, N3, protec...  
JP2002544135A
(-- 57) summary -- the convenient large-scale manufacture synthetic method of D* elytrous fin ゴシン of high isomeric purity and セラミド is explained. 化 1  
JP2002543214A
Provided are L-ribo bicyclic nucleotide compounds as well as syntheses of such compounds. The nucleoside compounds of the invention are useful in forming oligonucleotides that can produce nucleobase specific duplexes with complementary s...  
JP3356324B2
Compounds of the general formula (I): wherein R1, R2, R3, R4, R5, R6, n and p are as herein defined; exhibit anticonvulsant activity and are thus useful in the treatment of conditions such as epilepsy. Compounds of this class are also us...  
JP2002537264A
The present invention relates to benzaldehyde derivatives which are useful as anticancer agents. Some of the compounds of this invention are novel per se.  

Matches 401 - 450 out of 863